GARS1 and peripheral neuropathy: Mutated glycyl-tRNA synthetase (GARS), causing Charcot-Marie-Tooth type 2D (CMT2D) peripheral neuropathy, fails to release charged tRNAGly (Mendonsa et al., 2021; Zuko et al., 2021).